{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T11:29:59Z","timestamp":1655206199035},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.anndiagpath.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,2,8]],"date-time":"2013-02-08T17:17:34Z","timestamp":1360343854000},"page":"270-275","source":"Crossref","is-referenced-by-count":2,"title":["Conventional endometrioid adenocarcinomas of the endometrium recurring as clear cell tumors: comparative immunohistochemical analyses"],"prefix":"10.1016","volume":"17","author":[{"given":"Kojo R.","family":"Rawish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Desouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta A.","family":"Crispens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwole","family":"Fadare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.anndiagpath.2013.01.001_bb0010","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ygyno.2006.02.011","article-title":"Follow-up after primary therapy for endometrial cancer: a systematic review","volume":"101","author":"Fung-Kee-Fung","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0020","first-page":"3391","article-title":"Relapse of endometrial carcinoma: follow-up of 272 patients with relapse","volume":"32","author":"Lindahl","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/GRF.0b013e318218c6d1","article-title":"Recurrent endometrial cancer","volume":"54","author":"Del Carmen","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0030","article-title":"Histologic patterns of recurrent endometrial carcinoma","author":"Cesari","year":"2011"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0040","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/PAS.0b013e318273591a","article-title":"Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma","volume":"36","author":"Soslow","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/onc.2012.76","article-title":"Endometrial carcinoma: molecular alterations involved in tumor development and progression","volume":"32","author":"Yeramian","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PAI.0b013e31824973d1","article-title":"Diagnostic utility of hepatocyte nuclear factor 1-Beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma","volume":"20","author":"Fadare","year":"2012","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0060","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1073\/pnas.0702507104","article-title":"Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity","volume":"104","author":"Saal","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0065","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.0806514106","article-title":"Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation","volume":"106","author":"Salvesen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IGC.0b013e31820575f5","article-title":"Evolution in endometrial cancer: evidence from an immunohistochemical study","volume":"21","author":"Vandenput","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2011.12.443","article-title":"p53 is correlated with low BMI negative progesterone receptor status and recurring disease in patients with endometrial cancer","volume":"125","author":"Seeger","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ygyno.2009.11.018","article-title":"p53 alteration independently predicts poor outcomes in patients with endometrial cancer: a clinicopathologic study of 131 cases and literature review","volume":"116","author":"Lee","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0085","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/path.2011","article-title":"Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma","volume":"209","author":"Yuan","year":"2006","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2013.01.001_bb0090","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2559.2011.04106.x","article-title":"Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia","volume":"60","author":"Santacana","year":"2012","journal-title":"Histopathology"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913413000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913413000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T09:19:51Z","timestamp":1562663991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913413000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1092913413000026"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2013.01.001","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}